Antiparasitic agent atovaquone

Antimicrob Agents Chemother. 2002 May;46(5):1163-73. doi: 10.1128/AAC.46.5.1163-1173.2002.

Authors

Aaron L Baggish¹, David R Hill

Affiliation

¹ University of Connecticut School of Medicine, Farmington, Connecticut, USA.

No abstract available

Publication types

Review

MeSH terms

Animals
Antifungal Agents / pharmacology
Antifungal Agents / therapeutic use*
Antiprotozoal Agents / pharmacology
Antiprotozoal Agents / therapeutic use*
Atovaquone
Babesia / drug effects
Humans
Naphthoquinones / pharmacology
Naphthoquinones / therapeutic use*
Plasmodium / drug effects
Pneumocystis / drug effects
Pneumonia, Pneumocystis / drug therapy*
Protozoan Infections / drug therapy*
Protozoan Infections / parasitology
Randomized Controlled Trials as Topic
Toxoplasma / drug effects

Substances

Antifungal Agents
Antiprotozoal Agents
Naphthoquinones
Atovaquone